Clinical Guideline Alerts – December 2024
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2025 Guideline Central, All Rights Reserved.
Read More
InSights Hub
Showing 11 to 20 of 361
(Page 2)
Guideline Med Alerts & FDA Approvals – December 2024
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2025 Guideline Central, All Rights Reserved.
Read More
2025 ASCO Gastrointestinal Cancers Symposium – Conference Preview
The 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium will be held from Thursday, January 23 to Saturday, January 25, 2025, at Moscone West in San Francisco, CA. This symposium serves as an important platform for staying abreast of the most recent advancements in research and gaining insights from leading experts on […]
Read More
Upcoming Medical Conferences – January 2025
Discover upcoming medical conferences where you can connect with peers, earn CME credits, and stay informed about the latest advancements in your field. Be sure to check out our conference previews and recaps below to stay updated on the engaging educational events and cutting-edge research. Medical Conferences in January 2025 Conference Previews and Recaps Sign […]
Read More
Upcoming FDA Decisions – January 2025
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]
Read More
British Society for Rheumatology (BSR) – Guidelines International Series
In this edition of our Guidelines International Series, we delve into the British Society for Rheumatology (BSR), the foremost specialist medical society in the UK for rheumatology and musculoskeletal professionals dedicated to enhancing the quality of life for children and adults with rheumatic and musculoskeletal diseases. The BSR is well known for its comprehensive collection […]
Read MoreAlirocumab (Praluent/Regeneron) – Guidelines+ Monographs
In this edition of the Guidelines+ Monographs Series will delve into the medication alirocumab, marketed under the brand name Praluent® from Regeneron. Praluent (alirocumab) is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor indicated to reduce the risk of myocardial infarction, stroke, and unstable angina requiring hospitalization in adults with established cardiovascular disease, as […]
Read More
Comparing Thrombolytics for Acute Ischemic Stroke Guidelines – Guidelines Side-By-Side
In the United States in 2022, stroke accounted for 1 in 6 deaths related to cardiovascular disease, according to the Centers for Disease Control and Prevention (CDC). The incidence rate of stroke experienced a slight decrease from 41.1 per 100,000 in 2021 to 39.5 per 100,000 in 2022. Ischemic strokes make up approximately 87% of […]
Read More
Tecvayli Clinical Trial Results for Patients With Newly Diagnosed Multiple Myeloma – Guidelines+ Trials Spotlight
On October 25, 2022, the US Food and Drug Administration (FDA) granted approval for Johnson & Johnson’s Tecvayli® (teclistamab-cqyv) for the treatment of adult patients with relapsed or refractory multiple myeloma. This approval is specifically for patients who have previously received four or more prior lines of therapy, including a proteasome inhibitor, immunomodulatory drug, and […]
Read MoreIrinotecan Liposome Injection (Onivide/Ipsen) – Guidelines+ Monographs
Our latest edition of the Guidelines+ Monographs Series will delve into the medication irinotecan liposome injection, marketed under the brand name Onivyde® by Ipsen. Onivyde (irinotecan liposome injection) is a liposomal formulation of the topoisomerase I inhibitor irinotecan used in the treatment of pancreatic adenocarcinoma. Onivyde is indicated in combination with oxaliplatin, fluorouracil and leucovorin, […]
Read More